Unknown

Dataset Information

0

The effect of human immunodeficiency virus infection on adverse events during treatment of drug-resistant tuberculosis: A systematic review and meta-analysis.


ABSTRACT:

Background

Adverse events (AEs) during drug-resistant tuberculosis (DR-TB) treatment, especially with human immunodeficiency virus (HIV) co-infection, remains a major threat to poor DR-TB treatment adherence and outcomes. This meta-analysis aims to investigate the effect of HIV infection on the development of AEs during DR-TB treatment.

Methods

Eligible studies evaluating the association between HIV seropositivity and risks of AE occurrence in DR-TB patients were included in this systematic review. Interventional and observational studies were assessed for risk of bias using the Risk of Bias in Nonrandomized Studies of Intervention and Newcastle-Ottawa Scale tool, respectively. Random-effects meta-analysis was performed to estimate the pooled risk ratio (RR) along with their 95% confidence intervals (CIs).

Results

A total of 37 studies involving 8657 patients were included in this systematic review. We discovered that HIV infection independently increased the risk of developing AEs in DR-TB patients by 12% (RR 1.12 [95% CI: 1.02-1.22]; I2 = 0%, p = 0.75). In particular, the risks were more accentuated in the development of hearing loss (RR 1.44 [95% CI: 1.18-1.75]; I2 = 60%), nephrotoxicity (RR 2.45 [95% CI: 1.20-4.98], I2 = 0%), and depression (RR 3.53 [95% CI: 1.38-9.03]; I2 = 0%). Although our findings indicated that the augmented risk was primarily driven by antiretroviral drug usage rather than HIV-related immunosuppression, further studies investigating their independent effects are required to confirm our findings.

Conclusion

HIV co-infection independently increased the risk of developing AEs during DR-TB treatment. Increased pharmacovigilance through routine assessments of audiological, renal, and mental functions are strongly encouraged to enable prompt diagnosis and treatment in patients experiencing AEs during concomitant DR-TB and HIV treatment.

SUBMITTER: Lazarus G 

PROVIDER: S-EPMC7932087 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature

altmetric image

Publications

The effect of human immunodeficiency virus infection on adverse events during treatment of drug-resistant tuberculosis: A systematic review and meta-analysis.

Lazarus Gilbert G   Tjoa Kevin K   Iskandar Anthony William Brian AWB   Louisa Melva M   Sagwa Evans L EL   Padayatchi Nesri N   Soetikno Vivian V  

PloS one 20210304 3


<h4>Background</h4>Adverse events (AEs) during drug-resistant tuberculosis (DR-TB) treatment, especially with human immunodeficiency virus (HIV) co-infection, remains a major threat to poor DR-TB treatment adherence and outcomes. This meta-analysis aims to investigate the effect of HIV infection on the development of AEs during DR-TB treatment.<h4>Methods</h4>Eligible studies evaluating the association between HIV seropositivity and risks of AE occurrence in DR-TB patients were included in this  ...[more]

Similar Datasets

| S-EPMC7384398 | biostudies-literature
| S-EPMC9155613 | biostudies-literature
| S-EPMC8416474 | biostudies-literature
| S-EPMC4219090 | biostudies-other
| S-EPMC7802168 | biostudies-literature
| S-EPMC5509256 | biostudies-literature
| S-EPMC8388945 | biostudies-literature
| S-EPMC3108589 | biostudies-literature
| S-EPMC4740314 | biostudies-literature
| S-EPMC5885859 | biostudies-other